Marker Therapeutics MRKR
NASDAQ MRKR
$1.07 -0.06 (-5.31%)
At close: Oct 22, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Long-Term Debt Repayments (2013)

Updated

Marker Therapeutics (MRKR) posted Long-Term Debt Repayments of $23,000 for FY2016.

Analysis

Marker Therapeutics (MRKR) Long-Term Debt Repayments (2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 1.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 2.00 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 17.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Marker Therapeutics 17.87 Mn -42.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 139,000.00
Mar 31, 2013 108,600.00
API Access

Marker Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=MRKR&period=max&api_key=YOUR_API_KEY